Cleared Traditional

K252188 - EMLA (Elekta Evo) (FDA 510(k) Clearance)

Also includes:
EMLA (VersaHD) EMLA (Elekta Harmony Pro) EMLA (Elekta Infintiy) EMLA (Elekta Harmony) EMLA (Elekta Synergy)
Jan 2026
Decision
185d
Days
Class 2
Risk

K252188 is an FDA 510(k) clearance for the EMLA (Elekta Evo). This device is classified as a Accelerator, Linear, Medical (Class II - Special Controls, product code IYE).

Submitted by Elekta Solutions AB (Stockholm, SE). The FDA issued a Cleared decision on January 15, 2026, 185 days after receiving the submission on July 14, 2025.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.5050.

Submission Details

510(k) Number K252188 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 14, 2025
Decision Date January 15, 2026
Days to Decision 185 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code IYE - Accelerator, Linear, Medical
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.5050